Health-related quality of life in Japanese low-risk prostate cancer patients choosing active surveillance: 3-year follow
- PDF / 850,137 Bytes
- 7 Pages / 595.276 x 790.866 pts Page_size
- 74 Downloads / 175 Views
ORIGINAL ARTICLE
Health‑related quality of life in Japanese low‑risk prostate cancer patients choosing active surveillance: 3‑year follow‑up from PRIAS‑JAPAN Hiromi Hirama1 · Mikio Sugimoto1 · Nobuyuki Miyatake2 · Takuma Kato1 · Lionne D. F. Venderbos3 · Sebastiaan Remmers3 · Kenichiro Shiga4 · Akira Yokomizo4 · Koji Mitsuzuka5 · Ryuji Matsumoto6 · Takahiro Osawa6 · Takashige Abe6 · Hiroshi Sasaki7 · Shin Egawa7 · Iku Ninomiya8 · Katsuyoshi Hashine8 · Monique J. Roobol3 · Yoshiyuki Kakehi1 Received: 8 September 2020 / Accepted: 10 October 2020 © Springer-Verlag GmbH Germany, part of Springer Nature 2020
Abstract Purpose To evaluate the health-related quality of life (HRQoL) of Japanese men on active surveillance (AS) in the Prostate cancer Research International Active Surveillance study in Japan (PRIAS-JAPAN). Methods Participants were included in the PRIAS-JAPAN HRQoL study between January 2010 and March 2016. Their general HRQoL was assessed using a validated Japanese version of the Short-Form 8 Health Survey (SF-8) at enrolment and annually thereafter until discontinuation of AS. The SF-8 mental component summary (MCS) and physical component summary (PCS) of men on AS were compared with scores of the general population (norm-based score [NBS]: 50) and MCS and PCS scores for men following AS were analysed over time. We tested whether MCS and PCS scores over time explained discontinuation of AS. Results Five hundred and twenty-five patients enrolled, and the median age at baseline was 68 years. At enrolment and after 1-, 2-, and 3-year follow-ups, the PCS and MCS scores were significantly higher than the NBS of the general Japanese population except for the median PCS at 3 years. We found that age at diagnosis and time on AS negatively affected the PCS score of men on AS, while every additional year on AS led to a 0.27 point increase in MCS scores. Neither PCS nor MCS were predictors for discontinuation of AS. Conclusion Japanese men following an AS strategy for 3 years reported better HRQoL compared with the general population, indicating that monitoring Japanese low-risk prostate cancer patients can be an effective treatment strategy. Study registration Clinical trial registry—UMIN (University Hospital Medical Information Network); UMIN000002874 (2009/12/11) Keywords Active surveillance · HRQoL · Japanese cohort · Low-risk prostate cancer · Patient‐reported outcome measurement
Introduction The incidence of prostate cancer (PCa), especially earlystaged and favourable-risk, has increased in Japan [1] due to widespread use of the PSA test. To overcome overtreatment offering Japanese men diagnosed with such early-stage, favourable-risk PCa an active surveillance (AS) monitoring * Hiromi Hirama [email protected] Extended author information available on the last page of the article
strategy can reduce the side effects of invasive treatment. Large AS studies initiated in North America and Western Europe have shown low PCa mortality and high metastasisfree survival rates over the course of 5–15 ye
Data Loading...
